News
[Conference Review] 2024 Academic Annual Meeting of the Pain Branch of the Jiangsu Geriatrics Society
13 Dec,2024
From December 6 to 8, 2024, the 2024 Academic Annual Meeting of the Pain Branch of the Jiangsu Geriatrics Society and the 2024 Academic Annual Meeting of the Nanjing Metropolitan Area Pain Specialist Alliance and the 8th Jinling Pain Summit Forum and the 8th Quarter Doctor Cheng Pain Department Practical Technology Study Class-Nanjing Station was successfully held. This conference is hosted by the Jiangsu Geriatrics Society, hosted by the Second Affiliated Hospital of Nanjing Medical University, and organized by Nanjing Shuangwei Biotechnology Co., Ltd. on-site.
This grand meeting brought together more than a hundred experts and scholars in pain science from both inside and outside the province to conduct extensive exchanges on pain science guidelines, diagnosis and treatment strategies, treatment experiences, and the development, evidence-based basis, and clinical application experiences of platelet-rich plasma (PRP) therapy. This annual academic conference is not only an important platform for academic exchanges on pain but also an important opportunity to promote the development of the pain discipline. 42 experts in the field of pain science gave lectures and shared the latest research results and clinical experiences.
Platelet-rich plasma (PRP) can promote the body to release a variety of biologically active factors and has the effects of analgesic and repair. It has been used in osteoarthritis pain, tendonitis pain, low back pain, post-herpetic neuralgia, etc. A painful disease. In the special exchange on platelet-rich plasma (PRP) at the academic conference, experts introduced the history, current situation, and future of PRP technology and shared many clinical application experiences. The expert group also exchanged opinions at the mid-term finalization meeting of Jiangsu local standards for "Platelet Rich Plasma Preparation and Quality Control".
As a trustworthy medical device manufacturer and service provider in China, Shuangwei Biotechnology has been deeply involved in the field of safe blood transfusion and wound treatment for more than 30 years. Shuangwei Biotechnology's series of products plays an important role in the clinical application of pain medicine. Among them, the new product independently developed by our company, the disposable platelet-rich plasma (RPP) preparation kit, received great attention from the expert representatives attending the meeting. This product can realize fully enclosed automated preparation. The separation and extraction processes are fully enclosed and pollution-free. It is efficient and intelligent while ensuring the safety of blood components. The preparation concentration is accurately adjustable from 2 to 8 times, providing patients with personalized diagnoses and treatment plans. It realizes the intelligent operation of "one centrifugation, one-stop sealing, one-click preparation, one-click quality control, and one-click storage".
Previous article
Related News
Application of PRP in hair loss treatment
2024-12-28
2024-11-05